|
Annual neurosurgery volume (median [IQR])
|
400 [350; 700]
|
|
Number of neurosurgery beds (median [IQR])
|
63 [45; 116]
|
|
Reduction in neurosurgery case volume due to COVID-19
|
|
< 25%
|
20 (13.9)
|
|
26–50%
|
56 (38.9)
|
|
51–75%
|
42 (29.2)
|
|
76–100%
|
26 (18.1)
|
|
Reduction in number of dedicated neurosurgery ORs
|
|
Little to no reduction
|
66 (45.8)
|
|
Small reduction (< 1/3 of neurosurgery ORs)
|
6 (4.2)
|
|
Moderate reduction (< 2/3 of neurosurgery ORs)
|
13 (9.0)
|
|
Major reduction (≥ 2/3 of neurosurgery ORs)
|
19 (13.2)
|
|
No dedicated ORs (100% reduction of neurosurgery ORs)
|
9 (6.3)
|
|
Reduction in number of neurosurgery ICU beds
|
|
Little to no reduction
|
93 (64.6)
|
|
Small reduction (< 1/3 of total ICU beds)
|
8 (5.6)
|
|
Moderate reduction (< 2/3 of total ICU beds)
|
11 (7.6)
|
|
Major reduction (≥ 2/3 of total ICU beds)
|
15 (10.4)
|
|
No dedicated ICU beds (100% reduction of ICU beds)
|
9 (6.3)
|
|
Current number of ventilators (median [IQR])
|
9 [4; 20]
|
|
Number of hospitals with increased ventilators
|
42 (29.2)
|
|
Percentage increase in number of ventilators (median)
|
0.5%
|
|
Level of personal protection by neurosurgeons operating on COVID-19-negative patients
|
|
Routine gowning
|
73 (50.7)
|
|
Routine gowning with N95 mask
|
35 (24.3)
|
|
Gowns with junctions sealed, with air supply or self-contained breathing apparatus
|
21 (14.6)
|
|
Completely enclosed gowns with self-contained breathing apparatus
|
15 (10.4)
|
|
Scheduled neurosurgeries still being performed as planned on COVID-19 positive patients
|
34 (23.4)
|
|
At the peak of the pandemic, was there shortage of COVID-19 related supplies/PPE in the hospital?
|
|
Little or no disruption
|
40 (27.8)
|
|
Moderate disruption
|
71 (49.3)
|
|
Severe disruption
|
20 (13.9)
|
|
Level of personal protection by neurosurgeons operating on COVID-19-positive patients
|
|
Routine gowning
|
14 (9.7)
|
|
Routine gowning with N95 mask
|
17 (11.8)
|
|
Gowns with junctions sealed, with air supply or self-contained breathing apparatus
|
11 (7.6)
|
|
Completely enclosed gowns with self-contained breathing apparatus
|
101 (70.1)
|
|
Changes to pre-operative COVID-19 screening guidelines for CNS tumor patients
|
120 (83.3)
|
|
If yes, what changes?
|
|
Confirmation of COVID-19 status by laboratory test as negative
|
58 (48.4)
|
|
Screening for COVID-19 based on history, clinical manifestation, and imaging
|
62 (51.6)
|
|
Suspension of post-operative adjuvant therapy
|
52 (36.1)
|
|
If no, what measures have been taken to administer post-operative adjuvant therapy?
|
|
Home-based assisted treatment
|
4 (2.8)
|
|
Strict isolation, single room treatment
|
14 (9.7)
|
|
Intensive screening for COVID-19
|
29 (20.1)
|
|
Improving the protection level of doctors and patients
|
12 (8.3)
|
|
Referral to other hospitals
|
35 (24.3)
|
|
Staff training to operate ventilators?
|
93 (64.6)
|
|
Number of neurosurgeons/fellows per hospital (median [IQR])
|
16 (9; 30)
|
|
Personnel relocation from neurosurgery to other departments
|
91 (63.2)
|
|
Relocation of:
|
|
Neurosurgeons
|
68 (47.2)
|
|
Operating room nurses/technicians
|
35 (24.3)
|
|
Trainees
|
75 (52.1)
|
|
ICU nurses
|
91 (63.2)
|
|
Floor nurses
|
91 (63.2)
|
|
Routine continuation of research
|
21 (14.6)
|
|
Suspension of research
|
85 (59.0)
|
|
Modifications of research
|
31 (21.5)
|
|
Research personnel working from home
|
14 (9.7)
|
|
Clinical research continuing but basic science research suspended
|
3 (2.1)
|
|
Segregation of research personnel
|
14 (9.7)
|
|
Trainees permitted to perform cases
|
67 (46.5)
|
|
Trainees required to stay at home unless on call or critically needed
|
78 (54.2)
|
|
Medical students mandated to stay at home
|
104 (72.2)
|
